Drug Approval | September 15, 2023
Strides receives tentative USFDA approval for Dolutegravir tablets
The products will be manufactured at the company's facility in Bengaluru
The products will be manufactured at the company's facility in Bengaluru
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
This product would be manufactured at Lupin's Nagpur facility in India
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
Subscribe To Our Newsletter & Stay Updated
